Reuters logo
BRIEF-Navidea Biopharmaceuticals posts Q3 loss of $0.01 per share
November 7, 2017 / 10:33 PM / 16 days ago

BRIEF-Navidea Biopharmaceuticals posts Q3 loss of $0.01 per share

Nov 7 (Reuters) - Navidea Biopharmaceuticals Inc

* Navidea biopharmaceuticals reports third quarter 2017 financial results

* Q3 revenue $224,000 versus $1.8 million

* Q3 loss per share $0.01 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below